Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Imv Inc.

Headquarters: Halifax, NS, Canada
Website: N/A
Year Founded: 2000
Status: Out of Business

BioCentury | Jul 18, 2023
Management Tracks

Gosebruch named CEO of Neumora

Plus: Petti becomes CEO at Leucid Bio, and updates from Acelyrin, Larimar, Pharming and more
BioCentury | Dec 22, 2021
Management Tracks

ShouTi follows October debut by hiring Credit Suisse’s Ding as CFO

Plus: C4X, IMV and Neuvogen
BioCentury | Nov 24, 2021
Management Tracks

Piper joins Scorpion as CFO

Plus: Ampio, IMV, BD and more
BioCentury | Jun 9, 2021
Management Tracks

More C-suite changes for Karyopharm; plus moves at Intercept, Chinook, Palleon, Napo, IMV and more 

In another change in the C-suite of Karyopharm Therapeutics Inc. (NASDAQ:KPTI), Chief Commercial Officer John Demaree and SVP of Sales Perry Monaco are leaving to pursue other opportunities. The
BioCentury | Mar 19, 2020
Product Development

Roivant pivots towards ARDS in COVID-19; plus Italian studies of repurposed anti-inflammatories, vaccine updates and more

BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.
BioCentury | Jun 1, 2017
Financial News

Immunovaccine raises C$10M in bought deal

Items per page:
1 - 10 of 13